As per our report, the size of the Global Atopic Dermatitis Treatment Market is valued at USD 10.4 billion in 2019 and is expected to grow at a CAGR of 13.13% to reach USD 19.3 billion by 2024 during the forecast period 2019-2024.
The market is expected to progress at a modest pace through the forecast period. Launch of further biologics & small molecules, premium-priced drugs substituting generic first-line and second-line therapeutics, increasing incidence of Atopic Dermatitis, and improved diagnostics are expected to stoke the growth of the Atopic Dermatitis Treatment Market.
Atopic Dermatitis is an inflammatory skin disease. The degree of its severity varies from patient to patient. It usually begins in childhood and is mostly confined to the flexural surfaces of the body. It is highly prevalent. It is more commonly known as eczema. Itching, redness of the skin, cracking, weeping, etc. are symptoms of it. It is a long term disease. Low humidity, cold weather, seasonal allergies are the common causes of it. The pattern of the disease and its severity determine the kind of treatment it ought to receive.
MARKET DRIVERS
The major driving factor for the demand of the market is the rapidly increasing population across the globe. Growing incidences of skin allergies and chronic disorders are elevating the growth rate of the market to the extent. Atopic dermatitis disease severity ranges from patient to patient where the treatment procedures involved in the severity degree. This is also one of the common factors for the market to grow tremendously. Escalating expenditure on health care is enhancing the demand of the market. The growing popularity of these treatment procedures through digital advertisements is accelerating the growth rate of the atopic dermatitis treatment market.
MAJOR CHALLENGES
However, the dearth of skilled people in hospitals and clinics is quietly impeding the demand of the market. Fluctuations in the economic strategies are impacting negatively on the growth rate of the atopic dermatitis treatment market. Less availability of necessary equipment in rural areas remains a challenging factor for the market players. Also, the high cost of the treatment procedures due to advanced features is declining the growth rate of this market.
OPPORTUNITIES
Rising complications and side effects after the treatment procedure in some of the people are hindering the demand of the market. Government initiatives in improving the infrastructure of hospitals and clinics with the latest equipment everywhere are certain to create growth opportunities for the market. An increasing number of patients suffering from various skin disorders are greatly influencing the demand for this market.
Changes in climatic conditions are also an attribute to boost up the growth rate of the atopic dermatitis treatment market. The rise in the disposable income in both developed and developing countries are likely to bolster the demand of the market. Besides, the emergence of the latest technologies in the medical sector and the introduction of innovative procedures are magnifying the demand of this market.
Recent Developments in the Atopic Dermatitis Treatment Industry:
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2018 – 2024 |
|
Base Year |
2018 |
|
Forecast Period |
2019 - 2024 |
|
Segments Covered |
By Treatment Type, Route of Administration, Distribution channel, Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Covered |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Market Leaders Profiled |
Astellas Pharma Inc., Valeant Pharmaceuticals International, Inc., and Sanofi S.A. Other players in the market include Anacor Pharmaceuticals, Inc. Meda Pharmaceuticals, Regeneron Pharmaceuticals Inc., and Novartis International AG, Pfizer Inc., |
This market research report on Global Atopic Dermatitis Treatment Market has been segmented and sub-segmented into the following categories and analyzed market size and forecast until 2024.
Atopic Dermatitis Treatment Market Analysis - By Treatment Type
Based on treatment type, the drug treatment segment is holding the highest shares of the market with the rise in the prevalence of early diagnosis of the diseases. Investments in research and development institutes to improve the services in healthcare centres are bolstering the growth rate of the market.
Atopic Dermatitis Treatment Market Analysis - By Route of Administration
Based on route of administration, the topical segment is leading with dominant shares of the market whereas the oral segment is to have the highest CAGR in the coming years. Support from public and private organizations over managing all the operations in the hospitals and clinics only to provide effective treatment procedures is expanding the shares of the market.
Atopic Dermatitis Treatment Market Analysis - By Distribution Channel
Based on distribution channel, the hospital pharmacies segment is ruling with the highest shares of the market by owing to the increasing scale of hospitals and clinics all over. The increasing flow of patients to hospitals is fuelling the demand for the global Atopic Dermatitis Treatment Market.
Atopic Dermatitis Treatment Market Geographical Segmentation Analysis:
Regional Analysis:
North America is the leader in the global atopic dermatitis treatment market. New product launches, early treatment adoption, and lifestyle changes are the reasons behind it. Europe is the second-largest market. Heavy investment in R&D activities in this region is the cause of the observable trend mentioned above. Some of the European countries like Spain and the United Kingdom are expected to showcase promising growth from 2019 to 2024.
The Asia Pacific is predicted to be the fastest-growing in the global atopic dermatitis treatment market in the aforementioned forecast period. Japan is forecasted to register the highest CAGR during the same period. This extension of the region can be attributed to the significant unmet clinical needs of victims, increasing spending on healthcare, and the availability of adequate treatment.
Rapidly growing population, changing lifestyles and a paradigm shift towards western lifestyles, increasing R&D, and large target patient pool are the reasons attributable to the observable trend mentioned above. Latin America and MEA regions are anticipated to undergo sluggish growth in the aforementioned forecast period.
List of key market participants leading the Global Atopic Dermatitis Treatment Market profiled in this report are:
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Treatment Type
5.1.1 Introduction
5.1.2 Drug Treatment
5.1.2.1 Emollients
5.1.2.2 Antihistamines
5.1.2.3 Antibiotics
5.1.2.4 Corticosteroids
5.1.2.5 Calcineurin Inhibitors
5.1.3 Radiation Treatment
5.1.4 Y-o-Y Growth Analysis, By Treatment Type
5.1.5 Market Attractiveness Analysis, By Treatment Type
5.1.6 Market Share Analysis, By Treatment Type
5.2 Route of administration
5.2.1 Introduction
5.2.2 Topical
5.2.3 Oral
5.2.4 Y-o-Y Growth Analysis, By Route of administration
5.2.5 Market Attractiveness Analysis, By Route of administration
5.2.6 Market Share Analysis, By Route of administration
5.3 Distribution Channel
5.3.1 Introduction
5.3.2 Hospital Pharmacies
5.3.3 Retail Pharmacies
5.3.4 Online Pharmacies
5.3.5 Y-o-Y Growth Analysis, By Distribution Channel
5.3.6 Market Attractiveness Analysis, By Distribution Channel
5.3.7 Market Share Analysis, By Distribution Channel
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Treatment Type
6.1.3.3 By Route of administration
6.1.3.4 By Distribution Channel
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Treatment Type
6.1.4.3 By Route of administration
6.1.4.4 By Distribution Channel
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Treatment Type
6.1.5.3 By Route of administration
6.1.5.4 By Distribution Channel
6.2 North America
6.2.1 Introduction
6.2.2 United States
6.2.3 Canada
6.3 Europe
6.3.1 Introduction
6.3.2 U.K
6.3.3 Spain
6.3.4 Germany
6.3.5 Italy
6.3.6 France
6.4 Asia-Pacific
6.4.1 Introduction
6.4.2 China
6.4.3 India
6.4.4 Japan
6.4.5 Australia
6.4.6 South Korea
6.5 Latin America
6.5.1 Introduction
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Rest of Latin America
6.6 Middle East & Africa
6.6.1 Introduction
6.6.2 Middle-East
6.6.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Astellas Pharma Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Sanofi S.A.
8.3 Valeant Pharmaceuticals International, Inc.
8.4 Novartis International AG
8.5 Pfizer Inc.
8.6 Meda Pharmaceuticals
8.7 Regeneron Pharmaceuticals Inc.
8.8 Anacor Pharmaceuticals, Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
